![Mark Parry-Billings](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Mark Parry-Billings
Chairman at
SYNAIRGEN PLC
Profile
Mark Parry-Billings is Executive Chairman at Synairgen Plc starting in 2025.
Former roles include Chief Executive Officer at Topigen Pharmaceuticals, Inc. from 2007 to 2010, Chairman at Zymenex A, Director at Innovata Biomed Ltd., Director at pSiMedica Ltd., Principal at Schering Health Care Ltd., and Head-Corporate Drug Development at CHIESI Farmaceutici SpA. Education includes a doctorate from the University of Oxford.
Mark Parry-Billings active positions
| Companies | Position | Start |
|---|---|---|
| SYNAIRGEN PLC | Chairman | 2024-10-09 |
Former positions of Mark Parry-Billings
| Companies | Position | End |
|---|---|---|
Topigen Pharmaceuticals, Inc.
 Topigen Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops drugs for respiratory diseases | Chief Executive Officer | 2009-12-31 |
CHIESI Farmaceutici SpA
 CHIESI Farmaceutici SpA Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops and markets respiratory health, rare diseases and specialty care products | Corporate Officer/Principal | - |
Zymenex A/S
 Zymenex A/S BiotechnologyHealth Technology Engages in the research and development of therapeutics for life threatening diseases | Chairman | - |
Schering Health Care Ltd. | Corporate Officer/Principal | - |
Innovata Biomed Ltd.
 Innovata Biomed Ltd. Miscellaneous Commercial ServicesCommercial Services Engages in the research, development, and commercialization of respiratory drug delivery technologies | Director/Board Member | - |
Training of Mark Parry-Billings
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
11
1st degree connections
8
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 8 |
|---|---|
Schering Health Care Ltd. | |
Synairgen Plc
 Synairgen Plc Pharmaceuticals: MajorHealth Technology Discovers and develops drugs for respiratory disorders | Health Technology |
University of Oxford
 University of Oxford Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
CHIESI Farmaceutici SpA
CHIESI Farmaceutici SpA Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops and markets respiratory health, rare diseases and specialty care products | Health Technology |
Innovata Biomed Ltd.
Innovata Biomed Ltd. Miscellaneous Commercial ServicesCommercial Services Engages in the research, development, and commercialization of respiratory drug delivery technologies | Commercial Services |
pSiMedica Ltd.
 pSiMedica Ltd. Miscellaneous Commercial ServicesCommercial Services Researches and develops nanostructured porous silicon | Commercial Services |
Zymenex A/S
Zymenex A/S BiotechnologyHealth Technology Engages in the research and development of therapeutics for life threatening diseases | Health Technology |
Topigen Pharmaceuticals, Inc.
Topigen Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops drugs for respiratory diseases | Health Technology |
- Stock Market
- Insiders
- Mark Parry-Billings
